Administration of ipilimumab to a liver transplant recipient with unresectable metastatic melanoma.
Ranganath, Harsha A
Administration of ipilimumab to a liver transplant recipient with unresectable metastatic melanoma. [electronic resource] - Journal of immunotherapy (Hagerstown, Md. : 1997) Jun 2015 - 211 p. digital
Publication Type: Case Reports; Journal Article
1537-4513
10.1097/CJI.0000000000000077 doi
Antibodies, Monoclonal--administration & dosage
Antineoplastic Agents--administration & dosage
CTLA-4 Antigen--antagonists & inhibitors
Female
Humans
Ipilimumab
Liver Transplantation--adverse effects
Melanoma--drug therapy
Middle Aged
Neoplasm Staging
Treatment Outcome
Administration of ipilimumab to a liver transplant recipient with unresectable metastatic melanoma. [electronic resource] - Journal of immunotherapy (Hagerstown, Md. : 1997) Jun 2015 - 211 p. digital
Publication Type: Case Reports; Journal Article
1537-4513
10.1097/CJI.0000000000000077 doi
Antibodies, Monoclonal--administration & dosage
Antineoplastic Agents--administration & dosage
CTLA-4 Antigen--antagonists & inhibitors
Female
Humans
Ipilimumab
Liver Transplantation--adverse effects
Melanoma--drug therapy
Middle Aged
Neoplasm Staging
Treatment Outcome